Management of psoriasis patients with hepatitis B or hepatitis C virus infection

Table 3 Diagnosis and distribution of patients treated with ustekinumab according to the hepatitis B virus serological profile

Ref.	Diagnosis, n	Inactive carriers (HBsAg+), n	Occult carriers or resolved HBV (anti-HBc+, anti-HBs- or anti-HBs ± anti-HBc), n	Prophylaxis1, n	Reactivation, n
Navarro et al[53]	PsO 1	1	0	1 (Entecavir)	0
Chiu et al[60]	PsO 14	112	3	4 (Entecavir)	2
Hayashi et al[61]	PsO 5	0	5	0	0
Koskinas et al[62]	PsO 1	0	1	0	1
Steglich et al[63]	PsO 1	0	1	1 (Lamivudine)	0

¹Only inactive carriers;

²Six with diagnosis of chronic hepatitis. PsO: Psoriasis; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; HBc: Hepatitis B core.